KRYS

Krystal Biotech
$345.55
−$2.54 (−0.73%)Sep 10, 2026
8.5GreatMoatMint rating

MoatMint rates Krystal Biotech (KRYS) 8.5 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 7.5 out of 10.

Key metrics

The numbers that frame KRYS today
Market cap
$10.23B
P/E (TTM)
42.4
EV / FCF
38.1
Gross margin
94.6%
EV / Sales
22.3
ROIC
27.8%
Div yield
0%
Debt / equity
0.0
52wk Low
$136.73
52wk High
$382.54

KRYS stock rating

How KRYS scores on quality, value, growth, momentum and financial health
8.5out of 10
Great overallHealthy business, fair price
Quality7.5
Growth3.2
Momentum9.1
Value5.2
Financial Health9.3

Growth

Revenue and earnings trend for KRYS
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about KRYS
Is Krystal Biotech a good buy?
Yes. Krystal Biotech has excellent quality and excellent momentum. Both signals support the setup. Growth looks weak, a caveat that does not overturn the setup. We think Krystal Biotech is selling at a fair price.
What is the market capitalization of KRYS?
Krystal Biotech's market capitalization is $10.23B.
What is the P/E ratio for KRYS stock?
Krystal Biotech's current P/E ratio is 42.4.
What is the 52-week high for KRYS stock?
The 52-week high for Krystal Biotech is $382.54. The current close of $345.55 is 9.7% below that high.
What is the 52-week low for KRYS stock?
The 52-week low for Krystal Biotech is $136.73. The current close of $345.55 is 152.7% above that low.
Does KRYS stock pay dividends?
Krystal Biotech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KRYS?
Krystal Biotech's Debt / Equity ratio is 0.01.